US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Simplify High Yield ETF

20.85

+0.12000.58%

Volume:68.43K

Turnover:1.42M

Market Cap:367.48M

PE:- -

High:20.86

Open:20.76

Low:20.76

Close:20.73

52wk High:23.05

52wk Low:20.42

Shares:17.63M

Float Shares:17.63M

Volume Ratio:0.46

T/O Rate:0.39%

Dividend:1.72

Dividend Rate:8.25%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Arena REIT posts higher FY2026 profits and navigates tenant default risk

Steep Price Tag for AI Infrastructure Funding: BlackRock's QTS Sells Investment-Grade Bonds at High-Yield Rates with Sixfold Demand

Standard Chartered revamps leveraged finance team to focus on sponsors

Megawati Wijaya / Bloomberg

Global Corn Group shifts from debt restructuring to winding up key subsidiary to tackle audit disclaimer

Nostrum Oil & Gas launches tender offer amid revised debt restructuring and Kazakh tax disputes

SpaceX Bond Yields Surge into High-Yield Territory

Celldex presents first-in-human results for CDX-622

Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update

BioLineRx Drug Shows Anti-Tumor Activity In Brain Tumor Animal Models

Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/CDX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDX\",,,,,undefined,":{"symbol":"CDX","market":"US","secType":"STK","nameCN":"Simplify High Yield ETF","latestPrice":20.85,"timestamp":1787684709708,"preClose":20.73,"halted":0,"volume":68426,"delay":0,"changeRate":0.005788712011577472,"floatShares":17625001,"shares":17625001,"eps":0,"marketStatus":"Trading","change":0.12,"latestTime":"08-25 15:07:49 EDT","open":20.76,"high":20.86,"low":20.76,"amount":1424301.422608,"amplitude":0.004824,"askPrice":21,"askSize":432,"bidPrice":20.63,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":20.73,"sharesOutstanding":22225001,"nav":20.7944,"aum":366375352.93,"dividendRate":0.082518,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":20.73,"preClose":20.73,"latestTime":"19:30 EDT","volume":16,"amount":332.38,"timestamp":1787614203773,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.45916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDX\",,,,,undefined,":{"symbol":"CDX","floatShares":17625001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.45916,"shares":17625001,"dividePrice":1.7205,"high":20.86,"amplitude":0.004824,"preClose":20.73,"low":20.76,"week52Low":20.42,"pbRate":"--","week52High":23.05,"institutionHeld":0,"latestPrice":20.85,"committee":-0.62406,"eps":0,"divideRate":0.082518,"volume":68426,"delay":0,"ttmEps":0,"open":20.76,"prevYearClose":22.27,"prevWeekClose":20.68,"prevMonthClose":20.65,"prevQuarterClose":21.12,"fiveDayClose":20.8,"twentyDayClose":20.52,"sixtyDayClose":21.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDX\",params:#limit:5,,,undefined,":[{"date":"2026-07-28","symbol":"CDX","amount":0.13,"announcedDate":"2026-07-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-28","defaultRemindTime":1785245400000,"name":"Simplify High Yield ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-31","payableDate":"2026-07-28","currency":"USD","dateTimestamp":1785211200000,"payDate":"2026-07-31"},{"date":"2026-06-25","symbol":"CDX","amount":0.13,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"Simplify High Yield ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-05-26","symbol":"CDX","amount":0.12,"announcedDate":"2026-05-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-26","defaultRemindTime":1779802200000,"name":"Simplify High Yield ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-29","payableDate":"2026-05-26","currency":"USD","dateTimestamp":1779768000000,"payDate":"2026-05-29"},{"date":"2026-04-27","symbol":"CDX","amount":0.14,"announcedDate":"2026-04-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-27","defaultRemindTime":1777296600000,"name":"Simplify High Yield ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-30","payableDate":"2026-04-27","currency":"USD","dateTimestamp":1777262400000,"payDate":"2026-04-30"},{"date":"2026-03-26","symbol":"CDX","amount":0.15,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"Simplify High Yield ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDX\",market:\"US\",,,undefined,":[{"executeDate":"2022-03-28","recordDate":"2022-03-29","paymentDate":"2022-03-31","value":0.0631,"currency":"USD"},{"executeDate":"2022-04-26","recordDate":"2022-04-27","paymentDate":"2022-04-29","value":0.08882,"currency":"USD"},{"executeDate":"2022-05-25","recordDate":"2022-05-26","paymentDate":"2022-05-31","value":0.10303,"currency":"USD"},{"executeDate":"2022-06-27","recordDate":"2022-06-28","paymentDate":"2022-06-30","value":0.09614,"currency":"USD"},{"executeDate":"2022-07-26","recordDate":"2022-07-27","paymentDate":"2022-07-29","value":0.06047,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661258567","title":"Arena REIT posts higher FY2026 profits and navigates tenant default risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258567","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258567?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:03","pubTimestamp":1787267031,"startTime":"0","endTime":"0","summary":"An announcement from Arena REIT ( ($AU:ARF) ) is now available. Arena REIT is an Australian real estate investment trust specialising in social inf...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arena-reit-posts-higher-fy2026-profits-and-navigates-tenant-default-risk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arena-reit-posts-higher-fy2026-profits-and-navigates-tenant-default-risk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFRA","RFCI","HFSI","SPBO","NHYB","HYBL","BSJO","PSCF","CDX","FLTB","JBBB","IVRA","BAMY","ZTOP","IBDY","RIGS","VGMS","JGH","MUSI","PPT","MYCI","PRIV","MDIV","TFLR","LQDM","VBCE","HBRD","YLDW","HYGV","EVV","JPIE","JHLN","IQRA","RMHY","BSCY","CRDT","CVRT","SHYL","VCLT","SIO","CCRP","TPFI","WBND","TMB","DYFI","RNTY","RJMG","JHCB","IG","BPRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196878801","title":"Steep Price Tag for AI Infrastructure Funding: BlackRock's QTS Sells Investment-Grade Bonds at High-Yield Rates with Sixfold Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1196878801","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196878801?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:38","pubTimestamp":1787085517,"startTime":"0","endTime":"0","summary":"Blackstone's data center arm, QTS Realty Trust, has completed an investment-grade bond issuance at yields nearing junk-bond levels to finance a data center for Microsoft, underscoring the escalating...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNDS","NHS","FLHY","BLHY","ODHY","RTRE","DHF","EAOR","EVHY","EAOM","JGH","MYHD","PRVT","FLXN","HYDB","BK4139","BSJW","PTRB","BBHY","ZBmain","BSJY","GPZ","HYDW","RIGS","VPLS","DINE","FSLD","YFYA","LEND","IE00B3QW5Z07.USD","DWFI","SJLD","JIII","HFSI","MAMB","XBB","BX","IE00BGHQF748.EUR","VLT","ABHY","ANGL","SJB","UJB","WEA","GBHI","UBmain","HNDL","PHYD","HYUP","DHY","AINP","BSJS","FSBD","IE00BN8TJ469.HKD","HYLS","IE0004445239.USD","BSJT","FIXD","HYGW","IBHI","USDX","SCCR","VBF","IE00BBT3K403.USD","HYB","GHYB","LOTI","STBF","WFHY","CAM","ZNmain","PHT","QHY","HYI","GHYG","HYTR","BGRN","INKM","MANI","BSJL","PCHI","EAOA","UCON","DUKH","TNmain","IVH","OPER","BHYB","NHYB","XAGG","IE00BLSP4452.SGD","BSJX","CPLB","IBHH","BGH","WBND","AWTM","FDHY","HYGM","HYXF","APLU","ZFmain","SCUB","IBHM","SDFI","THYF","AAUM","TXXI","RFCI","JNK","BSJO","CDX","CIK","ZTmain","MYHE","IBHG","CHYG","BSJV","JPLD","CRXP","VGHY","YLDW","GSST","JHCP","NBSD","ABXB","BSJJ","MHY","SSFI","THY","GMOC","HYRM","DABS","OVT","BSJP","SPLS","IBHB","BLTD","HYLV","IE00B64PRP62.GBP","FLXI","IHYF","FXED","IQHI","ADFI","SMTH","AAA","TRBF","BK4588","MYHC","VSDB","TOTR","BK4135","SCEC","BK4585","AOR","FLUD","HYHG","MSTI","IE00BLSP4239.USD","AHYB","BSJQ","PIM","FIXP","HYGV","LDRH","PFL","PSP","PULT","RISR","RDFI","LGOV","AGGA","CPHY","HYBX","LODI","PYLD","DFHY","JPIB","RAVI","WINC","FDTB","TMB","JPHY","GCSH","IBHE","JHHY","CGIB","DDX","MYHB","ISDB","PHYL","EDGF","BSJR","NUSB","TAXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660042237","title":"Standard Chartered revamps leveraged finance team to focus on sponsors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660042237","media":"Megawati Wijaya / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660042237?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:28","pubTimestamp":1787084912,"startTime":"0","endTime":"0","summary":"Standard Chartered's move is taking place at a time when deal-making is increasing and firms are looking to deploy more capital. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/banking-finance/standard-chartered-revamps-leveraged-finance-team-focus-sponsors?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/banking-finance/standard-chartered-revamps-leveraged-finance-team-focus-sponsors?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["LONZ","HYB","BSJQ","GHYB","MYHC","IHYF","BSJR","HYXF","DHY","XHYT","CDX","BHYB","EVHY","BRHY","GHYG","MYHA","BSJS","KI","HYGV","FSYD","HYBB","FDHY","HYLS","HIYS","HYLB","PSP","SPHY","NJNK","HYI","PHYL","SJB","HYBX","XCCC","JPHY","HYSA","SIHY","SCYB","CIK","JHHY","HYUP","LBO","HYGH","LRCY","DUKH","PHT","VLT","WFHY","BKHY","HYFI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657610011","title":"Global Corn Group shifts from debt restructuring to winding up key subsidiary to tackle audit disclaimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2657610011","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657610011?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:19","pubTimestamp":1786101576,"startTime":"0","endTime":"0","summary":"Global Sweeteners Holdings Limited ( ($HK:3889) ) has provided an update. Global Corn Group Limited has provided a quarterly update on efforts to r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/global-corn-group-shifts-from-debt-restructuring-to-winding-up-key-subsidiary-to-tackle-audit-disclaimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/global-corn-group-shifts-from-debt-restructuring-to-winding-up-key-subsidiary-to-tackle-audit-disclaimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCY","ZCmain","JPIB","CDX","XCmain","GAEM","BSDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653035479","title":"Nostrum Oil & Gas launches tender offer amid revised debt restructuring and Kazakh tax disputes","url":"https://stock-news.laohu8.com/highlight/detail?id=2653035479","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653035479?lang=en_us&edition=fundamental","pubTime":"2026-07-24 23:32","pubTimestamp":1784907169,"startTime":"0","endTime":"0","summary":"An update from Nostrum Oil & Gas ( ($GB:NOG) ) is now available. Nostrum Oil & Gas B.V., a subsidiary of Nostrum Oil & Gas PLC, has launched a tender","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nostrum-oil-gas-launches-tender-offer-amid-revised-debt-restructuring-and-kazakh-tax-disputes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nostrum-oil-gas-launches-tender-offer-amid-revised-debt-restructuring-and-kazakh-tax-disputes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BSDE","GAEM","CDX","PCY","JPIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127148566","title":"SpaceX Bond Yields Surge into High-Yield Territory","url":"https://stock-news.laohu8.com/highlight/detail?id=1127148566","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127148566?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:10","pubTimestamp":1784117454,"startTime":"0","endTime":"0","summary":"SpaceX, a company whose market value once eclipsed that of Amazon and, at a fleeting peak, even surpassed Microsoft's. While it may one day reclaim such heights, its valuation has currently plunged...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQHI","AHYB","DUKH","UFO","THYF","ANGL","GHYG","BSJR","IBHG","HYGW","PHT","BSJP","JHHY","SJB","PHYD","DXYZ","GHYB","INSI","BBHY","VLT","MDPL","BSJQ","HYHG","XOVR","SPCH","BSJO","SPCG","SPCQ","BK4089","SSPC","SPCU","HYDW","DHF","LOFF","HYB","FDHY","HIMU","IGCB","BSJS","HYTR","SPCM","BSJT","SPCX","AINP","BGH","IBHE","DHY","SPAL","PHYL","JNK","SPAX","HYDB","SPCF","JHCB","QHY","FLHY","HYRM","SNK","IBDK","HYXF","CCSB","HYI","IBDY","LDRH","JGH","FDIV","FSLD","BSJJ","BK4615","XBB","PIM","HDLB","BSJW","BK4585","HYGV","SYSB","IBHI","THY","CDX","BSJV","HYBL","HYBX","IBHH","BK4588","HYLS","MOOD","EVHY","UJB","HYUP","BHYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643247739","title":"Celldex presents first-in-human results for CDX-622","url":"https://stock-news.laohu8.com/highlight/detail?id=2643247739","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643247739?lang=en_us&edition=fundamental","pubTime":"2026-06-15 04:50","pubTimestamp":1781470228,"startTime":"0","endTime":"0","summary":"Celldex (CLDX) presented positive results from the Phase 1 healthy participant study of CDX-622 at the European Academy of Allergy and Clinical Imm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celldex-presents-first-in-human-results-for-cdx-622-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celldex-presents-first-in-human-results-for-cdx-622-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLDX","BK4139","CDX","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638048955","title":"Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2638048955","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638048955?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:00","pubTimestamp":1779879600,"startTime":"0","endTime":"0","summary":"- Announced first patient dosed in Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma  -. - Announced new GLIX1 data demonstrating potent anti-tumor effect in GBM across multiple in-vivo studies, including a temozolomide -resistant patient-derived xenograft model -. - Management to host conference call today, May 27, at 8:30 am EDT -. TEL AVIV, Israel, May 27, 2026 /PRNewswire/ -- BioLineRx Ltd.  , a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its unaudited financial results for the quarter ended March 31, 2026, and provided a corporate update.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BK4232","LU2413666426.HKD","BK4022","IE00BYQQ9H92.USD","BLRX","CDX","BK4585","BK4139","IE00B5TLWC47.USD","PFS","LU0347712357.USD","BK4588","BK4121","LU1093756168.USD","LU2211817866.USD","R","BK4195","PDX","LU2413666699.HKD","LU1093756325.SGD","BK4533","LU1721428933.USD","BK4567","BK4548","MTD","IE00BFXG0V08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636860229","title":"BioLineRx Drug Shows Anti-Tumor Activity In Brain Tumor Animal Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2636860229","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636860229?lang=en_us&edition=fundamental","pubTime":"2026-05-20 06:28","pubTimestamp":1779229680,"startTime":"0","endTime":"0","summary":"BioLineRx, a commercial-stage biopharmaceutical company focused on oncology, and Hemispherian revealed new preclinical data showing GLIX1’s strong anti-tumor activity, even in a temozolomide -resistant model.In the threeorthotopic cell-derived xenograft  studies,significant tumor growth inhibition and survival benefit were observed following treatment with GLIX1 across all doses tested, with greater benefit at higher dose levels.In these models,mice treated with TMZ also showed significantly decreased tumor volume and survival benefit.Most notably, inthe subcutaneous PDX model, GLIX1 demonstrated a robust anti-tumor effect while TMZ showed no effect.The finding highlights the potential of GLIX1 to address the significant unmet needs of patients suffering from glioblastoma, an aggressive form of cancer.In April, BioLineRx initiated a first-in-human, Phase 1/2a study of GLIX1 for the treatment of recurrent and progressive GBM and other high-grade glioma.BLRX Price Action: BioLine Rx shar","market":"nz","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=630,dpr=2,format=auto,quality=85/files/images/story/2026/05/19/Cancer---Heart-Shape-To-Represent-Medica.jpeg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=630,dpr=2,format=auto,quality=85/files/images/story/2026/05/19/Cancer---Heart-Shape-To-Represent-Medica.jpeg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/markets/biotech/26/05/52680140/biolinerx-drug-shows-anti-tumor-activity-in-brain-tumor-animal-models","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/biotech/26/05/52680140/biolinerx-drug-shows-anti-tumor-activity-in-brain-tumor-animal-models","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["CDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629877995","title":"Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629877995","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629877995?lang=en_us&edition=fundamental","pubTime":"2026-04-21 05:00","pubTimestamp":1776718800,"startTime":"0","endTime":"0","summary":"SHANGHAI, April  20, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3277510/0/en/Junshi-Biosciences-Presents-Results-from-JS207-PD-1-VEGF-BsAb-Phase-2-Combo-Studies-and-JS212-EGFR-HER3-ADC-FIH-Phase-1-2-Study-at-AACR-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","LU2413666426.HKD","BK1504","BK4023","ORR","LU1721428933.USD","CDX","BK4213","LU1093756168.USD","BK4588","LU1169589451.USD","LU2413666699.HKD","BK4121","LU2211817866.USD","BK1508","BK4533","LU1093756325.SGD","BK4548","BK4195","BK4006","BK4231","BK4585","LU0347712357.USD","MTD","IE00BFXG0V08.USD","PD","IND","HCC","IE00B5TLWC47.USD","SD","IE00BYQQ9H92.USD","BK4567","BK1167","LU1169590202.USD","PFS","BK4080","ADC","PR","02038"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}